Umesh Kumar Recognized for Pioneering Contributions to Clinical Operations and Healthcare Data Science

Hyderabad, July 18, 2025 — Umesh Kumar, Associate Director of Clinical Operations at IQVIA RDS (India) Private Limited, has emerged as a distinguished leader in the field of clinical research and healthcare data science. With over 17 years of extensive experience across clinical data science, Artificial Intelligence (AI), Machine Learning (ML), big data, biotechnology, biostatistics, pharmacovigilance, data management, and medical writing, Umesh has led impactful work across the USA, UK, EU, Canada, and Asia.

For the past 8 years, he has held the position of Associate Director at IQVIA RDS, where he provides strategic leadership in outsourcing initiatives and risk-based monitoring. His contributions span major therapeutic areas including oncology, diabetes, infectious diseases, vaccines, and ophthalmology. In these domains, he has played critical roles as a data manager, statistician, and team leader conducting global clinical trials.

Recognizing his excellence in healthcare innovation and data-driven strategies, Umesh Kumar was conferred with the Excellence in Healthcare Award at the prestigious Health 2.0 Conference held in Las Vegas, USA in 2025.

Umesh’s leadership extends beyond operational execution. He has contributed to standard operating procedures (SOPs), training programs, scientific publications, and has led task forces addressing key industry challenges. His thought leadership is also reflected through numerous speaking engagements at renowned platforms such as Elets Pharmaceutical Users Software Exchange (PHUSE), Indian Association for Statistics in Clinical Trials (IASCT), D Y Patil University, Biotecnika, Health 2.0, and Alard University.

As a prolific author, Umesh has published extensively on topics like digital healthcare technology, clinical statistical programming, and the evolving role of data science in global clinical research.

Umesh Kumar continues to inspire as a visionary professional blending technology, science, and strategy to drive innovations in healthcare and clinical development.